ATR and neoplasm: The combination of selective ATR inhibitor, avelumab, and platinum-based chemotherapy resulted in antitumor effect in syngeneic tumor models, leading to overall survival benefit compared to any dual-combination group, and also provided protective antitumor immunity with immunological memory in cured mice [170].